Lines of Thought / Topic
Medical devices: the line so far
6 developments and 19 rules, in date order. Built automatically from everything tagged with this topic.
- Rule · In forceINICMR AI health ethics guidelines
- Rule · ProposedIDDraft AI Perpres
- Rule · In forceUS-UTUtah AI Policy Act
- Rule · Partly in forceEUEU AI Act
Also on Project Meridian and the race to govern military AI, Transparency, not licensing, Who decides if a medical AI is safe?
- Rule · In forceUS-UTUtah mental-health chatbot law
- Rule · In forceKEKenya National AI Strategy
- Rule · In forceUS-ILIllinois AI therapy ban (WOPR Act)
- Rule · Partly in forceUS-CACCPA ADMT regulations
Also on Can an algorithm deny your care?, Who audits the hiring algorithm?
- Rule · In forceITItalian AI Law
- Rule · In forceUS-NYNY AI companion law
- FDA loosens oversight of AI decision-support software and health wearables
More AI tools used by clinicians and consumers can reach market without FDA clearance, shifting safety assurance to developers and health systems.
- MASAI trial: AI-supported mammography screening cuts interval cancers by 12%
It is the first randomised evidence that AI in population screening improves a hard clinical outcome, strengthening the case for national programmes to adopt it.
- Rule · ProposedKEKenya AI Bill
- NHS England updates AI scribe guidance and launches supplier registry
It turns AI scribes from local experiments into a regulated NHS product category with a minimum compliance bar for suppliers.
- EU deal keeps AI medical devices under AI Act high-risk rules, delayed to 2028
Medtech makers selling AI devices in Europe must plan for dual MDR and AI Act conformity, with one extra year to prepare.
- Rule · Enacted, not yet in forceUS-COSB 26-189 (Colorado ADMT law)
- Rule · In consultationEUHigh-risk classification guidelines (draft)
- Rule · In forceEUDigital Omnibus on AI
- FDA proposes a risk framework for generative AI medical devices
It is the first concrete sign of how FDA might clear LLM-based clinical tools, and comments will shape whether chatbots and scribes need premarket review.
- Rule · Enacted, not yet in forceUS-CASB 1119 / Adam's Law
- UK accepts all 44 recommendations of doctor-led commission on regulating health AI
Medical-AI makers selling in the UK should expect ongoing monitoring duties after approval, not a one-off clearance, bringing the UK closer to the FDA's lifecycle approach.